.@intel and @GreenstoneBio are working together to speed up the development of new medicine, combining state of the art human genetics and biology from Greenstone with advanced computing platforms from Intel. This work will allow rapid drug discovery at lower cost. This combination of human biology and AI computing will shape the future of biomedicine in the coming years. I’m amazed by the work my longtime friend Dr. @Joseph_C_Wu and his team are doing, and we are excited about the potential of this partnership.
Greenstone Biosciences is partnering with @illumina to advance precision drug discovery. This collaboration combines Greenstone’s extensive iPSC biobank with Illumina’s cutting-edge single-cell and spatial genomics technologies.
Read More: https://t.co/W2UucpoaMy
We’re excited to announce that @GreenstoneBio is partnering with @nvidia to accelerate drug discovery through the application of advanced AI foundational models, combining NVIDIA's computational power with our drug discovery methods
Read more: https://t.co/qJ0N9P1cUY
We are excited to announce the next installment of our Greenstone Biosciences webinar series, featuring Dr. William Pu. Professor of Pediatrics at Harvard Medical School on Tuesday, October 28th.
Learn more: https://t.co/5FPZxnR37V
Secure your spot: https://t.co/dASWXGkAhX
We’re excited to announce that our GSB team now offers comprehensive gut permeability assays to support drug discovery.
These assays help evaluate:
- Barrier dysfunction in disease models
- Drug-induced effects on tight junctions
- Restoration of barrier integrity
We’re excited to share that Dr. Todd Herron, Director of our hiPSC Biobank, will be a featured speaker in the upcoming Cellular Insights Series: Innovations and Ethics in Stem Cell Research.
Date: October 23, 2025
Time: 12:00 – 1:00 PM ET
Sign up here: https://t.co/4j9zaK3DoW
The question is no longer whether #NAMs will transform drug development, but rather which organizations will lead this transformation and capture its substantial value creation opportunity.
#FDA#biotech#Organoids#drugdevelopment#pharma
https://t.co/V5TeGlFfx0
https://t.co/Skwk6M8bgx, forecast from London Business School on business trends shaping 2025, and it hits close to home for those of us navigating the biotech and drug discovery world. Takeaways:
1. AI + Blockchain Integration
2. AI as “Teammates”
3. Sustainability at the Core
On behalf of Greenstone Biosciences, I'd like to wish everyone a joyful holiday season and a prosperous New Year! Thank you to our partners, colleagues, and community for being part of our journey this year. Looking forward to continued innovation and collaboration in 2025!
❄️ Happy Holidays from all of us at Greenstone Biosciences! ❄️
As we wrap up another year, we want to extend our warmest wishes to our incredible collaborators, partners, and supporters.
May this winter season bring you joy, rest, and renewed energy.
#HappyHolidays
Our AI-driven platform proves that precision medicine can develop safer, more effective therapies by understanding cellular mechanisms at the molecular level.
Read the full study: https://t.co/t7Pp3Y1hvl
#DrugDiscovery#Biotechnology#Innovation#PrecisionMedicine
Proud to see our commentary on New Approach Methods and iPSCs in Nature Reviews Drug Discovery! Explore the potential of these technologies in drug development.
#DrugDiscovery#NAM#iPSCs#FDA#DrugDevelopment
https://t.co/5wVcNhcLCm
If you are attending @SOToxicology meeting stop by at the Greenstonebio booth 637 to learn about #hiPSCs and get freebies! Ask Celine and Sushma how you can acquire cell lines for GSB for free.
Greenstone Biosciences will be at #2024SOT! If you’re headed to Salt Lake City for the 2024 @SOToxicology
meeting and #ToxExpo, drop by our Booth No. 637 to learn more about our exciting work and how you too can have access to our free #iPSCs as an academic lab. #toxicology
R44 grant funded! This is our first federal grant to take #GreenstoneBio iPSC biobank to the next level and commercialize our collection of over 2000 lines. Be it differentiation into particular lineage or complex drug discovery models, we are at it, and ready to help. #biotech
🔬 Merging tech & biology for a brighter future! Patient-derived iPSC cells + AI/ML-driven drug discovery are reshaping how we find treatments. More personal, ethical, and efficient than ever before! 🧬💡 #iPSCxAI#NextGenMedicine#DrugDiscoveryRevolution
https://t.co/tE0DhAkofq
@Andrew_Akbashev My postdoc years taught me invaluable skills in independent thinking. Contrary to the notion that academia is the only path, I chose the industry and have no regrets. Don't underestimate the importance of what you can learn during your postdoc journey.